Zeo ScientifiX (ZEOX) Times Interest Earned (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Times Interest Earned of -$46.55 for Q2 2026, up 29.88% year-over-year from -$35.84 in Q2 2025, and up 46.99% quarter-over-quarter from -$87.8 in Q1 2026.
Zeo ScientifiX (ZEOX) Times Interest Earned (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Times Interest Earned history runs 14 years deep, the most recent figure standing at -$46.55 for Q2 2026.
- In Q2 2026, Times Interest Earned rose 29.88% year-over-year to -$46.55; the TTM figure through Apr 2026 stood at -$54.33 (up 8.76% YoY), while the FY2025 annual figure was -$0.65, up 20.34% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$46.55, up from -$87.8 in the prior quarter.
- The five-year high for Times Interest Earned was -$8.41 in Q3 2023, with the low at -$90.04 in Q3 2025.
- The 5-year median for Times Interest Earned is -$42.71 (2022), against an average of -$44.05.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned soared 97.7% in 2022, then plunged 504.05% in 2024.
- Zeo ScientifiX's Times Interest Earned stood at -$42.37 in 2022, then soared by 67.69% to -$13.69 in 2023, then sank by 373.18% to -$64.77 in 2024, then surged by 67.77% to -$20.88 in 2025, then slumped by 122.97% to -$46.55 in 2026.
- Business Quant data shows ZEOX's Times Interest Earned at -$46.55 in Q2 2026, -$87.8 in Q1 2026, and -$20.88 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -46.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -46.55 |
| Jan 31, 2026 | -87.80 |
| Oct 31, 2025 | -20.88 |
| Jul 31, 2025 | -90.04 |
| Apr 30, 2025 | -66.38 |
| Jan 31, 2025 | -56.95 |
| Oct 31, 2024 | -64.77 |
| Jul 31, 2024 | -50.78 |
| Apr 30, 2024 | -78.20 |
| Jan 31, 2024 | -43.04 |
| Oct 31, 2023 | -13.69 |
| Jul 31, 2023 | -8.41 |
| Apr 30, 2023 | -17.55 |
| Jan 31, 2023 | -35.67 |
| Oct 31, 2022 | -42.37 |
| Jul 31, 2022 | -20.67 |
| Apr 30, 2022 | -8.43 |
| Jan 31, 2022 | -40.73 |
| Oct 31, 2021 | 71.92 |
| Jul 31, 2021 | -71.53 |